|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
$183,741
|
N/A
|
National Institutes of Health
|
|
Role of ASXL1 mutations in myeloid malignancies
|
5K08CA160647-04
|
$169,884
|
$169,884
|
ABDEL-WAHAB, OMAR
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
|
3R01CA140622-03S1
|
$17,593
|
$17,593
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
|
3R01CA140622-04S1
|
$52,545
|
$52,545
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
|
5R01CA140622-04
|
$371,660
|
$371,660
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Role of p27 in chronic myeloid leukemia and its potential as a therapeutic target
|
4R00CA151670-03
|
$241,470
|
$241,470
|
AGARWAL, ANUPRIYA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S5
|
$10,116,159
|
$101,162
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S6
|
$75,000
|
$750
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S7
|
$122,667
|
$1,227
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Adult Leukemia Research Center
|
5P01CA018029-39
|
$4,098,686
|
$163,947
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)
|
5R01CA160433-03
|
$326,066
|
$326,066
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
1R01CA184798-01A1
|
$785,520
|
$785,520
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Improved therapeutic approaches for hematological disorder treated with tyrosine
|
5R01CA155091-03
|
$307,951
|
$307,951
|
AZAM, MOHAMMAD
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S1
|
$74,856
|
$1,497
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S2
|
$122,401
|
$2,448
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S3
|
$150,000
|
$3,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-40
|
$4,421,130
|
$88,423
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Cancer Center Support Grant
|
3P30CA042014-25S1
|
$75,000
|
$2,250
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-25S2
|
$33,333
|
$1,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-25S3
|
$148,179
|
$4,445
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-25
|
$1,505,000
|
$45,150
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA006516-49S1
|
$118,825
|
$1,188
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-49S2
|
$75,000
|
$750
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-49S3
|
$12,500
|
$125
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-49
|
$10,827,666
|
$108,277
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer and Leukemia Group B Human Specimen Repositories
|
3U24CA114725-09S1
|
$1,014,550
|
$507,275
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
MOLECULAR STUDIES OF BONE MARROW FAILURE
|
5R01CA105312-09
|
$561,426
|
$561,426
|
BESSLER, MONICA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Resistance of CML Stem Cells to Imatinib (Gleevec)
|
5R01CA095684-11
|
$305,276
|
$305,276
|
BHATIA, RAVI
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Microenvironmental Regulation of Leukemia Stem Cells
|
5R01CA172447-02
|
$338,142
|
$338,142
|
BHATIA, RAVI
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-04
|
$170,100
|
$85,050
|
BLEAKLEY, MARIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia
|
5R01CA165469-02
|
$369,860
|
$369,860
|
BONDADA, SUBBARAO
|
UNIVERSITY OF KENTUCKY
|
|
Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia
|
5R01CA173085-02
|
$318,099
|
$318,099
|
BRAUN, BENJAMIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
|
5R01CA167169-02
|
$311,976
|
$311,976
|
CALABRETTA, BRUNO
|
THOMAS JEFFERSON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S1
|
$75,000
|
$1,500
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S2
|
$125,000
|
$2,500
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S3
|
$135,233
|
$2,705
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S4
|
$149,838
|
$2,997
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-38
|
$4,444,835
|
$88,897
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
|
5R01CA166280-02
|
$308,958
|
$308,958
|
CALVI, LAURA
|
UNIVERSITY OF ROCHESTER
|
|
Cancer Center Support Grant
|
3P30CA082103-16S2
|
$49,999
|
$1,000
|
CARROLL, PETER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-16S3
|
$74,999
|
$1,500
|
CARROLL, PETER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA082103-16
|
$7,049,997
|
$141,000
|
CARROLL, PETER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
The Therapy of CML
|
5P01CA049639-24
|
$3,477,908
|
$3,477,908
|
CHAMPLIN, RICHARD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Role of Shp2 in FLT3-ITD-Induced Leukemogenesis
|
5R01CA134777-04
|
$309,964
|
$309,964
|
CHAN, REBECCA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Roles of SIRT1 in normal hematopoietic and leukemic stem cells
|
5R01CA143421-04
|
$304,328
|
$304,328
|
CHEN, WENYONG
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Fanconi anemia pathway in DNA damage repair
|
5R01CA157448-03
|
$318,015
|
$318,015
|
CHEN, JUNJIE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Mechanism of novel transmembrane proteins that induce erythroid differentiation
|
5F31CA168012-02
|
$6,416
|
$6,416
|
COHEN, EMILY
|
YALE UNIVERSITY
|
|
Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML
|
1R21CA159203-01A1
|
$177,197
|
$177,197
|
COREY, SETH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Genetic Analysis of Myeloproliferative Disease
|
2R01CA076167-11
|
$305,269
|
$305,269
|
COWELL, JOHN
|
GEORGIA REGENTS UNIVERSITY
|
|
Mechanisms of Leukemogenesis in Down Syndrome
|
5R01CA101774-12
|
$294,846
|
$294,846
|
CRISPINO, JOHN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $36,747,316
|